Clearstead Trust LLC Takes $36,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Clearstead Trust LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the first quarter, Holdings Channel.com reports. The institutional investor acquired 352 shares of the medical device company’s stock, valued at approximately $36,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. SG Americas Securities LLC raised its stake in shares of Cooper Companies by 220.9% during the fourth quarter. SG Americas Securities LLC now owns 4,326 shares of the medical device company’s stock valued at $1,637,000 after acquiring an additional 2,978 shares during the last quarter. Raymond James & Associates raised its position in Cooper Companies by 2.3% during the 4th quarter. Raymond James & Associates now owns 143,961 shares of the medical device company’s stock worth $54,481,000 after purchasing an additional 3,298 shares during the last quarter. Portside Wealth Group LLC raised its position in Cooper Companies by 4.7% during the 4th quarter. Portside Wealth Group LLC now owns 2,432 shares of the medical device company’s stock worth $920,000 after purchasing an additional 110 shares during the last quarter. Assenagon Asset Management S.A. lifted its holdings in Cooper Companies by 207.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 42,493 shares of the medical device company’s stock worth $16,081,000 after buying an additional 28,669 shares during the period. Finally, Altfest L J & Co. Inc. grew its position in shares of Cooper Companies by 22.5% in the 4th quarter. Altfest L J & Co. Inc. now owns 1,257 shares of the medical device company’s stock valued at $476,000 after buying an additional 231 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and increased their target price for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Citigroup upped their price target on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, May 31st. Piper Sandler reaffirmed an “overweight” rating and set a $115.00 target price on shares of Cooper Companies in a research report on Wednesday, July 3rd. Finally, Robert W. Baird boosted their price target on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a report on Friday, May 31st. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average price target of $111.78.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded down $0.57 during midday trading on Friday, hitting $90.75. The company’s stock had a trading volume of 744,890 shares, compared to its average volume of 1,355,009. The stock has a fifty day moving average price of $91.75 and a 200 day moving average price of $94.29. The firm has a market capitalization of $18.07 billion, a price-to-earnings ratio of 53.30, a P/E/G ratio of 2.25 and a beta of 0.98. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $104.07. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million for the quarter, compared to the consensus estimate of $948.07 million. During the same quarter in the prior year, the business posted $0.77 earnings per share. The business’s quarterly revenue was up 7.4% on a year-over-year basis. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.